Atlas Lithium Corporation filings document the regulatory record for a Nevada lithium development company advancing the Neves Project in Brazil. Proxy materials cover annual meeting procedures, shareholder voting matters and board governance, while 8-K reports disclose director changes and other material corporate events.
Capital markets filings and related 8-K exhibits address the company's common stock, shelf registration statement, at-the-market offering program and prospectus supplements. Periodic reports referenced by the company provide risk-factor disclosure for Atlas Lithium and its subsidiaries, including project-development and critical-minerals operations.
Atlas Lithium Corp director and CEO Marc Fogassa reported a disposition of common stock to the issuer. On May 6, 2026, a transaction coded "D" shows 55,555 shares of Common Stock disposed of at $5.513 per share, described as an issuer disposition.
According to a footnote, this disposition was effected by Goldman Sachs & Co. LLC pursuant to a previously established Rule 10b5-1 plan. After the transaction, Fogassa held 5,213,168 shares of Common Stock directly and 105,608 shares indirectly through entities controlled by him.
Atlas Lithium Corp Chief Executive Officer Marc Fogassa reported a disposition of common stock to the company. On April 22, 2026, 55,555 shares of common stock were disposed of to the issuer at $4.7446 per share, in a transaction effected by Goldman Sachs & Co. LLC pursuant to a previously established Rule 10b5-1 plan. Following this transaction, Fogassa directly holds 5,269,168 shares of common stock and indirectly holds 105,608 shares through entities he controls.
Atlas Lithium Corporation reported a wider net loss as it continues to invest heavily in developing its Brazilian lithium assets. For the three months ended March 31, 2026, net loss was $16.5 million versus $10.2 million a year earlier, driven mainly by higher general and administrative and stock-based compensation expenses.
Net revenue rose to $74,386 from $25,175, while cash and cash equivalents were $34.4 million and total assets $87.4 million. The company remains focused on advancing its Neves lithium project in Minas Gerais, supported by a DMS processing plant and an at-the-market equity program.
Atlas Lithium consolidated its 20.26% stake in Atlas Critical Minerals, which listed on Nasdaq and raised capital, and highlighted that Neves was named in a Japan-U.S. critical minerals cooperation fact sheet. Management believes existing liquidity will fund operations for at least twelve months, though continued external financing may be needed for long-term growth.
Atlas Lithium Corp director Roger Noriega sold common shares in two open-market transactions. He sold 5,000 shares at $5.54 and 7,725 shares at $5.50, for total reported sales of 12,725 shares. After these sales, he directly holds 242,476 Atlas Lithium common shares.
Tkachenko Igor reported acquisition or exercise transactions in this Form 4 filing.
Atlas Lithium Corp executive Igor Tkachenko, VP of Corporate Strategy, reported a compensation-related stock award. He received 7,692 shares of Common Stock at no cost, classified as a grant or award. Following this transaction, his direct holdings increased to 305,325 Atlas Lithium shares, reflecting a routine equity compensation grant rather than an open-market purchase.
Mitsui & Co., Ltd. reports beneficial ownership of 2,068,089 shares of Atlas Lithium Corporation common stock, representing 7.3% of the class based on 28,205,239 shares outstanding as of April 17, 2025. The amendment reflects a lower ownership percentage caused by passive increases in Atlas Lithium’s shares outstanding over time.
On April 9, 2026, Mitsui acquired 196,839 Atlas Lithium common shares from the company in connection with services it provided. Mitsui holds sole voting and dispositive power over its reported shares.
Atlas Lithium Corp’s Chief Financial Officer Tiago Miranda reported two open-market sales of common stock. On April 16, he sold 4,400 shares at $5.00 per share, followed on April 17 by a sale of 5,831 shares at $5.03 per share.
The filing notes these dispositions were effected by XP Investments US LLC under a previously established Rule 10b5-1 trading plan, indicating the sales were pre-arranged. After these transactions, Miranda directly holds 30,000 shares of Atlas Lithium common stock.
Atlas Lithium Corp director Roger Noriega reported selling a total of 10,150 shares of common stock in open-market transactions. He sold 10,000 shares at $4.70 per share and 150 shares at $4.73 per share. After these sales, he holds 255,051 shares directly.
Atlas Lithium Corporation is calling a virtual 2026 annual stockholder meeting on May 28, 2026, to elect five directors, ratify Pipara & Co. LLP as auditor for 2026, hold a non-binding say-on-pay vote, and approve an updated non‑employee director compensation program.
The company is a Nasdaq-listed “controlled company,” as CEO and Chairman Marc Fogassa holds about 61.0% of voting power through common stock and a special Series A preferred share. The board has five members, four of whom are classified as independent under Nasdaq rules, and operates Audit, Compensation, and Nominations Committees.
Non‑employee directors currently receive annual stock options to buy 10,000 shares at $0.0075 per share; stockholders are asked to approve an increase to 15,000 options annually plus a 5,000‑share top‑up for 2026, while Admiral Flávio Rocha would instead receive cash fees. Named executive officer pay combines salary, bonuses and significant equity-based incentives, and prior say‑on‑pay support was strong. Large holders include Mitsui & Co., Ltd. and Citadel Advisors LLC.